In-vitro fragmentation of ovarian tissue activates primordial follicles through the Hippo pathway by De Roo, Chloë et al.
In-vitro fragmentation of ovarian tissue
activates primordial follicles through
the Hippo pathway
C. De Roo *, S. Lierman, K. Tilleman, and P. De Sutter
Department of Reproductive Medicine, Ghent-Fertility and Stem Cell Team (G-FaST), Ghent University Hospital, 9000 Ghent, Belgium
*Correspondence address. Department of Reproductive Medicine, Ghent-Fertility and Stem Cell Team (G-FaST), Ghent University
Hospital, C. Heymanslaan 10, 9000, Ghent, Belgium. E-mail: chloe.deroo@ugent.be https://orcid.org/0000-0002-6623-3283
Submitted on April 1, 2020; resubmitted on July 14, 2020; editorial decision on September 4, 2020
STUDY QUESTION: What is the role of the Hippo and PI3K/Akt pathway in follicles during ovarian tissue culture in tissue derived from
oncological patients and transgender men?
SUMMARY ANSWER: Results highlight a Hippo pathway driven primordial follicle activation in vitro, predominantly from Day 0
to Day 4.
WHAT IS KNOWN ALREADY: In-vitro ovarian tissue culture aims at activating and maturing primordial follicles for fertility restoration
in patients with a threatened ovarian reserve. Not all patients are eligible for ovarian cortex transplantation and therefore several groups
are attempting to culture ovarian tissue in-vitro. Cortex fragmentation disrupts the Hippo pathway, leading to increased expression
of downstream growth factors and follicle growth. The PI3K/Akt pathway is considered the intracellular pathway to where different
extracellular factors involved in primordial follicle activation in-vivo converge. In order to optimise current ovarian tissue culture models,
information on progression of these pathways during tissue culture is mandatory.
STUDY DESIGN, SIZE, DURATION: The first step of a multistep cortex culture system was performed using 144 ovarian cortex
pieces from a total of six patients. Per patient, 24 cortical strips were cultured for 6 days and six pieces per patient were collected for
downstream analysis of follicle development and Hippo and PI3K/Akt pathway targets every second day.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Ovarian tissue was obtained from oncological (N¼ 3; 28.67 § 4.51 years)
and transgender (N¼ 3; 23.33 § 1.53 years) patients. Follicles were analysed using haematoxylin-eosin staining and pathways were studied
using immunohistochemistry and precise follicle excision by laser capture micro-dissection for RT-qPCR analysis. MIQE guidelines for RT-
qPCR were pursued. Reference gene selection (GAPDH, RPL3A, 18s rRNA) was performed using GeNorm Reference Gene Selection Kit.
Statistical analysis was conducted with IBM SPSS Statistics 23 (Poisson regression, negative binomial regression, ANOVA and paired t-test).
MAIN RESULTS AND THE ROLE OF CHANCE: Immunohistochemical analysis confirmed a Hippo pathway driven primordial follicle
activation due to mechanical manipulation of the cortical strips. Ovarian tissue preparation and culture induced the inhibitory phosphory-
lated Yes-associated protein (pYAP) to disappear in granulosa cells of primordial follicles on Day 2. The stimulatory YAP on the contrary
appeared in primordial granulosa cells over increasing culture days. Looking at the YAP target connective tissue growth factor (CTGF), a
significantly up-regulated CTGF was noted in primordial follicles when comparing Day 2 and Day 4 (ratio Day 2/4¼ 0.082; P< 0.05),
clearly showing an effect on the Hippo pathway in primordial follicles during tissue culture. Follicle classification showed a significant drop
in estimated primordial follicle counts in the oncological cohort (78%; P¼ 0.021) on Day 2 and in the transgender cohort on Day 4
(634%; P¼ 0.008). Intermediate follicle counts showed a non-significant increasing trend to during culture and this follicle recruitment
and growth resulted in a significant rise in estimated primary follicle counts on Day 6 in oncological patients (170%; P¼ 0.025) and,
although limited in absolute numbers, a significant increase in secondary follicles on Day 4 (367%; P¼ 0.021) in the transgender cohort.
Subsequent antral follicle development could not be observed.
LIMITATIONS, REASONS FOR CAUTION: A limitation is the small sample size, inherent to this study subject, especially as a large
amount of tissue was needed per patient to reduce inter-patient variation in different downstream analysis techniques. A particular and
specific weakness of this study is the inability to include an age-matched control group.
VC The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits
non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com











































WIDER IMPLICATIONS OF THE FINDINGS: These findings support an adapted tissue preparation for Hippo pathway disruption and
a shorter first phase of tissue culture. This work may also have implications for transplantation of cryopreserved tissue as larger strips (and
thus slower burnout due to less Hippo pathway disruption) could be a benefit.
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tegen Kanker, TBMT001816N), the Flemish Foundation of Scientific Research (FWO Vlaanderen, FWO G0.065.11N10) and the Gender
Identity Research and Education Society (GIRES) foundation. The authors declare no competing interests.
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Introduction
Human ovarian tissue cryopreservation is a fertility preservation tech-
nique that has been performed for many years, gradually shifting from
an experimental to a clinically implemented fertility preservation ap-
proach (De Vos et al. 2014; Donnez et al., 2015). The goal of storing
ovarian tissue is to safeguard the primordial follicle pool for destructive
influences originating from gonadotoxic treatments. Autologous trans-
plantation of the stored tissue in post-pubertal women most com-
monly orthotopically (Demeestere et al., 2009; Donnez and Dolmans,
2014), but also heterotopically (Stern et al., 2014), has resulted in
more than 130 births worldwide (Donnez and Dolmans, 2017;
Ladanyi et al., 2017). However, not all patients are eligible for trans-
plantation and therefore several groups have attempted to culture
ovarian tissue in-vitro (Kawamura et al., 2013; Suzuki et al., 2015;
Ladanyi et al., 2017). The common goal of both transplantation and in-
vitro culturing of ovarian tissue is to activate, mature and use the resid-
ing primordial follicle pool for fertility restoration in patients with a
threatened ovarian reserve, including cancer patients facing a gonado-
toxic treatment, transgender men undergoing a (bilateral) oophorec-
tomy, patients diagnosed with primary ovarian insufficiency and
women facing aging-associated subfertility (Donnez and Dolmans,
2013; De Vos et al., 2014).
An efficient use of the cryopreserved cortical follicular reserve
remains a challenge. In order to produce meiotically and developmen-
tally competent oocytes through in-vitro tissue culturing, many hurdles
still remain (Telfer and Zelinski, 2013). Since the majority of cortical
follicles are primordial, the first challenge is an effective, efficient and
balanced activation of this dormant follicle pool in-vitro (Telfer and
Zelinski, 2013). Transplanting ovarian tissue does indeed successfully
activate the dormant follicle pool. The graft lifespan, however, and
thus reproductive potential of the grafted tissue, is limited (4–5 years)
(Schmidt et al., 2005; Donnez et al., 2011, 2013), due to a very effec-
tive, but unbalanced activation of the primordial follicles resulting in an
early follicle burnout (Meirow et al., 2015). This delicate equilibrium of
controlled activation is the result of the complex combination of inhibi-
tory and stimulatory factors of primordial follicle activation
(Hsueh et al., 2015). The promising advances in tissue culturing and
transplantations should therefore be fine-tuned according to this bal-
ance to increase their efficacy.
In this context, two pathways, the Hippo pathway and the PI3K/
Akt pathway, are of interest (Grosbois and Demeestere, 2018). The
Hippo pathway mediates a reciprocal relationship between cell–cell
contact growth inhibition and mitogenic signalling (Gumbiner and
Kim, 2014). Fragmentation of the cortex, thereby disturbing cell–cell
contact, and molecular targeting of the pathway, for instance with
sphingosine-1-phosphate, were found to disrupt the Hippo signalling,
leading to an increased expression of downstream growth factors
and follicle growth (Yu et al., 2012; Kawamura et al., 2013, 2016;
Hsueh et al., 2015). The PI3K/Akt pathway on the other hand is
considered the intracellular pathway to where the different extracellu-
lar factors involved in primordial follicle activation in-vivo converge
WHAT DOES THIS MEAN FOR PATIENTS?
Freezing of ovarian tissue is a technique to store immature oocytes in patients with a threatened ovarian reserve, including cancer patients
facing chemotherapy or radiotherapy, transgender men undergoing resection of the ovaries, patients diagnosed with primary ovarian insuffi-
ciency and women facing aging-associated subfertility. Current use of this frozen tissue is transplantation; however, this is not possible for
all patients. Therefore, activation of the resting oocyte pool and further maturation is being developed in a laboratory setting.
The first step of a previously described multistep culture system with tissue derived from oncological patients and transgender men was
repeated and two molecular pathways of interest for follicle development were studied. Studying the progression of the pathways during
culture and follicle development confirmed the activation of the most immature of follicles (primordial follicles) due to cutting and stretching
of the tissue. Different levels of activation were discovered when comparing the patient groups, most possibly due to an altered tissue stiff-
ness after testosterone therapy in the transgender men. Overall, our findings recommend a shorter first phase in this multistep tissue cul-
ture to increase the efficacy of this culture. This change might lead to more efficient procedures for using frozen tissue to obtain mature
oocytes in a laboratory setting.
























































































(Hsueh et al., 2015). A number of extracellular ligands involved in
primordial follicle growth have been identified, including kit ligand,
vascular endothelial growth factor and insulin-like growth factor I
(Hsueh et al., 2015). The exact trigger of primordial follicle activation
remains unidentified; however, all these factors tend to have a com-
mon intracellular pathway, the PI3K/Akt pathway. In order to optimise
the current ovarian tissue culture models, detailed information on the
progression of these pathways during tissue culture and immature folli-
cle development is needed. Unravelling this progression is mandatory
to identify clues to a more effective use of primordial follicles in-vitro.
Another barrier to advancements in follicle research is the simple
fact that an ovary consists of various cell types, such as connective tis-
sue, neurons, follicles, stromal cells and blood vessels (Shea et al.,
2014). These different cell types possibly contain different pathway
molecules, all influencing the bidirectional paracrine communication be-
tween the follicle and surrounding somatic cells, making it very difficult
to distinguish the inhibitory and stimulatory factors of primordial follicle
activation (Woodruff and Shea, 2007; Shea et al., 2014; Hsueh et al.,
2015). This heterogeneous ovarian composition limits target-specific
analysis of the follicular unit, especially in transcriptome analysis as
these methods require isolation of pure cell populations (Fend and
Raffeld, 2000). Therefore, laser capture micro-dissection (LCM) for
separate collection of follicles and stromal cells can be applied
(Markholt et al., 2012). LCM combines visualisation of the cells of
interest by light microscopy and targeting of these specific cells with
laser beam technology (Fend and Raffeld, 2000).
In order to accurately evaluate the changes in the Hippo and PI3K/
Akt pathway, we repeated the first step of the promising multistep
cortex culture system developed by the group of E. Telfer (Telfer
et al., 2008). Follicle count and classification using haematoxylin/eosin
(HE) staining and a follicle-specific analysis of the Hippo and PI3K/Akt
pathway using LCM, RT-qPCR and fluorescent immunohistochemistry
(IHC) were performed. To be able to implement our findings for
further research or for a future clinical setting, ovarian tissue from two
target patient populations was used: post-pubertal oncological patients
and post-pubertal transgender men.
Methods
Patient inclusion and workflow
Ethical approval was obtained from the Ghent University hospital insti-
tutional review board under reference 2012/780, with Belgian registra-
tion number B670201 21 5468. This study was performed in
accordance with good clinical practice guidelines and written informed
consent was obtained from all patients. In total, 144 ovarian cortex
pieces from a total of six patients were used in this study. From these
six patients, ovarian tissue was obtained from three deceased oncolog-
ical patients (28.67§ 4.51 years), who consented to donate their cryo-
preserved ovarian tissue to research post-mortem. These patients
underwent unilateral oophorectomy for fertility preservation purposes
prior to chemotherapy. Oncological indications for fertility preserva-
tion comprised acute lymphoblastic lymphoma, breast cancer and
acute myeloid leukaemia. None of the patients received chemo- and/
or radiotherapy before the oophorectomy. In parallel, three post-
pubertal age-matched transgender men (23.33§ 1.53 years) consented
to donate their ovarian tissue upon bilateral oophorectomy for
gender-confirming surgery. All transgender men included in this study
received intramuscular testosterone undecanoate 1000 mg every
12 weeks during 55.33§ 1.15 weeks as cross-sex hormone treatment
prior to the oophorectomy. Per patient, 24 cortical strips were cul-
tured for 6 days and six pieces per patient were collected for down-
stream analysis every second day (Fig. 1). Analyses included HE
staining for follicle classification, RT-qPCR on LCM obtained follicles
for transcriptome analysis and fluorescent IHC to study the localisation
of different targets on the Hippo and PI3K/Akt pathway (Fig. 2).
Pathway targets analysed by RT-qPCR were mammalian sterile 20-
like protein kinase I and II (Mst1 and Mst2), WW domain scaffolding
protein Salvador (SAV1), large tumour suppressor homologues 1 and
2 (LATS1 and LATS2) and connective tissue growth factor (CTGF).
To study protein phosphorylation as well as potential spatial dynamics
of the pathway molecules in the oocyte, granulosa cells and surround-
ing stroma, IHC for Mst1, Yes-associated protein (YAP) and
phosphorylated YAP (pYAP), phosphatidylinositol-4,5-bisphosphate
3-kinase (PI3K), protein kinase B (PKB) also known as Akt and
phosphorylated Akt (pAkt), Fork head box O1 (FOXO1) and phos-
phorylated FOXO1 (pFOXO1) was applied.
Ovarian tissue collection and processing
Immediately after hysterectomy with bilateral oophorectomy, the
entire ovaries were transported to the laboratory on ice, in Leibovitz
L-15* medium (Life Technologies, Ghent, Belgium), supplemented
with 0.45% human serum albumin (Red Cross, Belgium). The ovaries
were bisected and the medulla was carefully removed by scraping
with a scalpel to prepare the cortical tissue to the required thickness
of 1 mm. This cortex was subsequently fragmented in pieces of
5  5 mm2. The fragments were cryopreserved by controlled slow-
freezing and stored in liquid nitrogen, as described elsewhere (Lierman
et al., 2015).
Tissue preparation and culture
The cortical tissue culture system was adapted from the first phase of
the two-step culture model as described by E. Telfer (Telfer et al.,
2008). The frozen vial containing the cortical fragment was thawed in
a warm water bath at 37C for 2 min. Following three wash steps in
Leibovitz L-15* medium (Life Technologies, Ghent, Belgium), supple-
mented with 0.45% human serum albumin (Red Cross, Belgium) for
5 min, the ovarian cortex (5  5  1 mm3) was pulled mechanically
using the blunt end of a scalpel to flatten out the tissue and to mini-
mise the underlying stroma. To ensure an adequate number of follicles
per strip for downstream analysis, larger fragments of ovarian cortex
were cultured compared with the protocol by E. Telfer (Telfer et al.,
2008). The tissue was halved (2.5  5  1 mm3) and cut into small
interconnecting strips per 1 mm (Fig. 1). These interconnecting strips
were further transversely incised (but not fragmented) per 1 mm to
mimic the 1 mm3 as described by E. Telfer (Telfer et al., 2008). The
cortical comb-like strips were transferred individually in 24-well culture
plates (Corning B.V. Life Sciences Europe, Amsterdam, The
Netherlands) containing 300ml of McCoy’s 5a medium with bicarbon-
ate supplemented with HEPES (20 mM), HSA (0.1%) (Red Cross,
Belgium), glutamine (3 mM) (Thermo Scientific, Merelbeke, Belgium),
penicillin G (0.1 mg/ml)-streptomycin (0.1 mg/ml) (Thermo Scientific),






































transferrin (2.5mg/ml), selenium (4 ng/ml), insulin (10 ng/ml) and
ascorbic acid (50mg/ml), all obtained from Sigma-Aldrich (Bornem,
Belgium), unless stated otherwise. As described by E. Telfer (Telfer
et al., 2008), tissue pieces were cultured for 6 days at 37C in humidi-
fied air with 5% CO2 with medium change and collection of six cortical
strips per each patient every second day. To serve as a reference on
Day 0 in different downstream analyses, six cortical fragments (5  5
 1 mm3) per patient were taken and fixed in 10% buffered formalin
immediately after thawing and prior to tissue preparation. On culture
Days 2, 4 and 6, the pair of interconnecting strips were considered as
one cortical fragment (resulting in twice 2.5  5  1 mm3) in order
to analyse a constant ovarian cortex surface of 5  5  1 mm. Every
second culture day, six pairs of interconnecting strips per patient were
fixed in 10% buffered formalin (Sigma-Aldrich, Bornem, Belgium) for
4 h, followed by dehydration and paraffin embedding. These paraffin-
embedded tissue cubes were stored at 20C until further use.
Follicle classification
From the six cortical strips per patient collected every second day,
two cortical strips were fixed in 10% buffered formalin (Sigma-Aldrich,
Bornem, Belgium) for a maximum of 24 h and embedded in paraffin
(Thermo Scientific, Erembodegem, Belgium). The paraffin-embedded
ovarian cortical tissue piece was serially sectioned at 5mm, resulting in
10 slices of 5  5 mm2 (surface)  5mm (depth), and stained with
(Mayer) haematoxylin (Merck, Overijse, Belgium) and eosin (Thermo
Scientific, Merelbeke, Belgium). Follicles were analysed using an
inverted microscope with a 40 magnification. Follicles were classified
according to the Gougeon classification for human follicles (Gougeon,
1986), as described and illustrated previously (De Roo et al., 2017).
Follicles were classified on the section containing the nucleus to avoid
double counting. Two independent observers analysed the follicles and
the mean of the two observations was used for further analysis.
Hence, the follicle count sometimes resulted in decimal numbers.
Laser capture micro-dissection
The paraffin-embedded ovarian cortical tissue piece was serially sec-
tioned at 5mm using diethylpyrocarbonate (DEPC) water in the micro-
tome bath and mounted on RNAse-free membrane polyethylene
naphthalene (PEN) membrane glass slides (Zeiss, Zaventem, Belgium)
and immediately processed further. Consecutively, the slides were
deparaffinised, dehydrated, stained and rehydrated: xylene (5 min
twice), isopropyl alcohol (1 min), disolol (1 min), 70% ethanol (1 min),
rinsed in DEPC water, Mayer’s haematoxylin (1 min), rinsed in DEPC
water, eosin yellow (10 s), 70% ethanol (20 dips), disolol (15 dips) and
isopropyl alcohol (10 dips), all products obtained from ChemLab,
Figure 1. Study design. In total, 144 cortex fragments (24 fragments per patient, N¼ 6 patients) were collected, prepared and cultured for
6 days. During tissue preparation, the ovarian cortexwas pulled mechanically using the blunt end of a scalpel to flatten out the tissue and
subsequently halvedand cut into small interconnecting strips. These interconnecting comb-like strips were further transversely incised (but not frag-
mented) per 1 mm (d). Scale bar ¼ 5 mm. Every second day, six fragments per patient were collected for downstream (HE staining, LCM-RT-qPCR
or fluorescent IHC) analysis. HE, haematoxylin/eosin; LCM, laser capture micro-dissection; RT-qPCR, reverse transcription-quantitative polymerase
chain reaction; IHC, immunohistochemistry.























..Zedelgem, Belgium. All reagents were prepared with DEPC-treated
water. Stained samples were immediately used for LCM.
Laser capture micro-dissection was performed using the PALM
Micro Beam System (P.A.L.M./Zeiss Micro Laser Technologies,
Munich, Germany). Follicles and surrounding stromal cells were
separately collected per follicle type resulting in selection of primordial
follicles, granulosa cells surrounding the primordial follicle, intermediate
follicles, granulosa cells surrounding the intermediate follicle, primary
follicles, granulosa cells surrounding the primary follicle, secondary
follicles and granulosa cells surrounding the secondary follicles.
This resulted in the collection of eight different cell types per
patient per culture day. Following visualisation, selection and micro-
dissection of the targeted cells, the micro-dissected tissue piece is
catapulted against gravity and collected in a collection device.
This guarantees contamination-free isolation of pure cell populations
(Niyaz et al., 2005). Cells were catapulted using the laser pressure cat-
apulting function and collected in the cap of a 200ml tube containing
40ml of RNeasy RLT Lysis Buffer (Qiagen, Antwerp, Belgium) with 1%
of b-mercaptoethanol (Life Technologies, Ghent, Belgium).
RNA extraction and cDNA synthesis
Follicles and surrounding stromal cells were separately collected per
follicle type. Surrounding stromal cells in this setting were defined as
the equal width of the corresponding granulosa cell layer width.
Additionally, per culture day, stromal cell at a distance from follicles
(equals at least 1 microscope field distance from a follicle at 20 mag-
nification) was collected as well. An overview of the collected material
using laser capture micro-dissection, with details on number and total
surface of collected follicles and stromal cells can be found in
Figure 2. Analysis techniques and targets of interest on the Hippo and PI3K/Akt pathway. Upper panels: LCM to collect follicle and
stromal cells separately by focusing on cells of interest (a), cutting (b), catapulting (c) and collecting (d) of follicles and cutting (e), catapulting (f) and
collecting (g) of surrounding stromal cells (illustration shows transgender intermediate follicle on culture Day 0). Underneath, example of IHC
for YAP (green dye) and pYAP (red dye) in transgender secondary follicle on culture Day 2, illustrating parallel staining of chromatin (DAPI),
unphosphorylated and phosphorylated protein on same section. Lower panels: simplified Hippo and PI3K/Akt pathways with focus on targets
of interest. *Pathway targets analysed by RT-qPCR, †Pathway targets analysed by immunohistochemistry. LCM, laser capture micro-dissection;
RT-qPCR, reverse transcription-quantitative polymerase chain reaction; IHC, immunohistochemistry; Mst 1/2, mammalian sterile 20-like protein ki-
nase I and II; SAV1, WW domain scaffolding protein Salvador; LATS1/2, large tumour suppressor homologues 1 and 2; CTGF, connective tissue
growth factor; YAP, Yes-associated protein; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; FOXO1, Fork head box O1. Scale bar ¼ 50 mm.

























































Supplementary File S1. The cells of interest (eight batches: primordial
follicles, granulosa cells surrounding the primordial follicle, intermediate
follicles, granulosa cells surrounding the intermediate follicle,
primary follicles, granulosa cells surrounding the primary follicle, sec-
ondary follicles and granulosa cells surrounding the secondary follicles)
were collected in vials per follicle type per patient per day, transported
on ice and immediately processed further. To minimise handling time
during RNA extraction, samples were processed in batches of a maxi-
mum of eight vials. All follicles and surrounding cells per data point
were collected. Therefore, the number of cells was dependent on the
follicle number (9.64§ 11.28, min 1, max 48) resulting in ranging cell
surfaces per vial from 72 666.91§ 89 618.04 lm2 (min 5530, max
349 190) for follicles to 122 103.50§ 147 573.48 lm2 (min 7540,
max 739 475) for stromal cells (Supplementary File S1). Total RNA
was extracted on ice using the RNeasy FFPE kit (Qiagen, Antwerp,
Belgium) according to the manufacturer’s protocol. Since the samples
were laser captured, total RNA extracted was too low to permit qual-
ity assessment (Bustin et al., 2009). To avoid RNA disintegration, con-
version into cDNA was performed immediately on ice using the
iScript advanced cDNA synthesis kit for RT-qPCR (Biorad, Temse,
Belgium). CDNA concentration was determined using Qubit fluoro-
metric quantitation method (Life Technologies, Ghent, Belgium). The
obtained cDNA was stored 80C until use.
Quantitative real-time PCR and reference
gene selection
To ensure quality, MIQE guidelines for RT-qPCR were pursued
(Vandesompele et al., 2002; Hellemans et al., 2007; Bustin et al.,
2009). Primers for Mst1, Mst2, SAV1, LATS1, LATS2 and CTGF were
designed using Primer Blast software (http://www.ncbi.nlm.nih.gov/
tools/primer-blast) (Taylor and Mrkusich, 2014), checked with
Netprimer software (http://www.premierbiosoft.com/netprimer/in
dex.html) and subsequently commercially obtained (Invitrogen,
Thermo Fisher Scientific, Belgium). Primers were tested for their opti-
mal annealing temperature and the obtained PCR product was vali-
dated in silico (Table I). Reference gene selection was performed using
the GeNorm Reference Gene Selection Kit for follicles and stromal
cells separately (Primer design, Rownhams Southampton, UK) using
qBaseþ (BioGazelle, Ghent, Belgium). For normalisation of the target
gene expression in follicles, the geometric mean of three reference
genes (GAPDH, RPL3A and 18s rRNA) was used. For normalisation
of the target gene expression in stromal cells RPL13A, EIF4A2 and
B2M were used as reference genes.
RT-qPCR was performed in technical duplicates on a CFX96
TouchTM Real-Time PCR Detection System (Biorad, Temse, Belgium)
using iTaq Universal Sybr Green Supermix (Biorad, Temse, Belgium).
Each quantitative PCR (qPCR) reaction included 15 ll master mix and
5 ng cDNA and was performed at optimal annealing temperature in
hard-shell low-profile thin-wall 96-well skirted PCR plates, sealed with
adhesive film. No template (water) was used as negative control.
Thermo-cycling conditions were as follows: 3 min at 95C followed by
40 cycles of 10 s at 95C followed by 1 min at optimal annealing tem-
perature (Table I).
Immunohistochemistry
Ten paraffin-embedded, sectioned ovarian tissue slices were mounted
on glass slides (1 slide per target protein pair (¼protein þ phosphory-
lated protein)), deparaffinised and hydrated. Sections were permeabi-
lised and antigens were retrieved in 0.05% Tween 20 (Sigma-Aldrich,
Bornem, Belgium) in sodium citrate buffer at 95–100C for 20 min.
After beaker temperature decreased below 35C, slides were washed
in PBS for 2  3 min. Primary antibodies (monoclonal rabbit anti-
human Mst1 (clone EPR6207, Abcam, Cambridge, UK), monoclonal
mouse anti-human YAP (clone number not available, Abcam,
Cambridge, UK), monoclonal rabbit anti-human pYAP (clone
EP1675Y, Abcam, Cambridge, UK), monoclonal rabbit anti-human
PI3K p110a (clone C73F8, Bioke, Leiden, The Netherlands), monoclo-
nal mouse anti-human Akt (clone 9Q7, Thermo Scientific, Merelbeke,
Belgium), monoclonal rabbit anti-human pAkt (clone 14-6, Thermo
Scientific, Merelbeke, Belgium), monoclonal mouse anti-human
FOXO1 (clone 7H3, Thermo Scientific, Merelbeke, Belgium) and poly-
clonal rabbit anti-human pFOXO1 (Thermo Scientific, Merelbeke,
Belgium)) were diluted in PBS with 1% BSA (1:100) and slides were in-
cubated at 4C overnight. The next day, the slides were washed with
1 PBS two times for 5 min. Secondary antibodies (polyclonal goat
anti-mouse IgG Alexa fluor 488 (Abcam, Cambridge, UK) and poly-
clonal goat anti-rabbit IgG Alexa fluor 594 (Abcam, Cambridge, UK))
were diluted in PBS þ 1% BSA (1:200) and slides were incubated for
1 h at room temperature. Finally, slides were washed three times in
1 PBS for 3 min and mounted in Vectashield with 40,6-diamidino-2-
phenylindole (DAPI) (Lab consult SPRL, Brussels, Belgium). Staining
without primary antibody was used as negative control for all targets
analysed. As a positive control, human ovarian granulosa tumour cell
line COV434 (Sigma-Aldrich, Bornem, Belgium) (positive for Mst1,
YAP, pYAP, PI3K, FOXO1 and pFOXO1) and tissue sections of
mouse liver (positive for YAP, Akt and pAkt) were used. Follicles
were analysed using a digital, inverted microscope for fluorescence
applications with light cubes for DAPI, GFP and Texas red (EVOSTM
FL Color Imaging System, Thermo Scientific, Merelbeke, Belgium). For
immunostaining, positive and negative controls were included per
......................................................................................................
Table I Target gene primer details.
Target Primer sequence Tm optimal
(C)
Mst1 Forward: AGCACCGATTTACGCCAGAA 54C
Reverse: CCGTACCTTTGGTCTCACCC
Mst2 Forward: TCCCTCTTTCCGCAAACCTC 63.3C
Reverse: GATTTGGAGGGGGTCCGAAG
SAV1 Forward: GCGGGGAAAGTTTACGGGAT 66.5C
Reverse: CAGTCGCTGGTCAGTTCCTT
LATS1 Forward: CGACGCTCACGAACGATCAG 54C
Reverse: ATGTAGCCCACACGAAGGAC





























































































































batch of eight slides to be stained and microscope settings
were adapted to these controls prior to analysis of the corresponding
slides. Per patient, per culture day, all follicles in 10 stained ovarian tis-
sue slices were classified and per follicle stage, target protein presence
and localisation were described in oocyte, granulosa cells and
surrounding stromal cells. Conclusions were drawn on general protein
patterns per follicle per culture day, resulting in descriptive non-
quantitative results.
Statistical analysis
Statistical analysis was conducted with IBM SPSS Statistics 23 (IBM
Corp., New York, USA). The inter-observer variation in HE follicle
classification was verified according to Bland-Altman’s limits of agree-
ment. If the difference between the two observations exceeded a sin-
gle standard deviation, the section was counted again.
For the follicle counts, outcome variables were all count data. The
fits for a Poisson regression and a negative binomial regression were
compared. Based on Akaike Information Criterion (AIC, it was de-
cided to perform a negative binomial regression. Follicle counts were
analysed using a negative binomial regression. For the outcomes fol-
licles classification, a negative binomial regression was performed with
culture day, patient group (oncological/transgender) and their interac-
tion as fixed factors, and individual patients as random factor (model
1). A negative binomial regression with the culture day as fixed factor
and individual patients as random factor was applied on the whole
dataset (if the interaction patient group * culture day was not signifi-
cant) on the subset with oncological patients and on the subset with
transgender men (model 2). For each day, counts for oncological
patients were compared to counts for transgender men using a model
containing group as fixed factor and individual patients as random
factor.
For the RT-qPCR experiments, Cq values were normalised to the
three identified reference genes and analysed using the ANOVA and
paired t-test on fold change gene expression using the inbuilt statistical
software in qBaseþ (Primer design, Rownhams Southampton, UK).
Gene expression was studied comparing different culture days, differ-
ent follicle classifications, overall and per patient type (transgender and
oncological patients). P< 0.05 was considered to be statistically
significant.
Results
In-vitro fragmentation of ovarian tissue
activates primordial follicles
Follicles originating from transgender ovarian tissue
In the ovarian cortex originating from transgender men, a total of
2099 follicles with a mean of 699.67§ 242.06 follicles per patient and
524.75§ 166.04 follicles per culture day were counted
(Supplementary File S2). On Day 0, the follicle distribution on a total
of 584 follicles was: 283 (48.46%) primordial, 188.5 (32.28%) interme-
diate, 106 (18.15%) primary, 4 (0.68%) secondary and 2.5 (0.43%) an-
tral follicles (Fig. 3). During culture, the counts for primordial follicles
on Day 4 were estimated to be 64% lower when compared to Day 0
(95% CI 83% to 23%; P¼ 0.008) (Fig. 3). Estimated counts for
intermediate and primary follicles did not change significantly during
culture (Fig. 3). In contrast, the estimated counts for secondary follicles
were significantly higher on Day 4 (compared to Day 0, an estimated
increase of 367%; 95% CI þ26% to þ1630%; P¼ 0.021); however,
this finding has to be interpreted with caution due to a limited absolute
number of secondary follicles (Fig. 3).
Follicles originating from oncological ovarian tissue
In the ovarian cortex originating from oncological patients, a total of
481.5 follicles with a mean of 160.50§ 92.00 follicles per patient and
120.38§ 56.47 follicles per culture day were counted (Supplementary
File S2). The follicle classification on Day 0 showed 112 (58.64%) pri-
mordial, 58 (30.37%) intermediate, 19.5 (10.21%) primary, 1 (0.52%)
secondary and 0.5 (0.26%) antral follicles (Fig. 3). On Day 0, primary
follicle counts were estimated to be 80% lower (95% CI 94% to
26%; P¼ 0.016) in the oncological group compared to the transgen-
der follicle counts on Day 0 whereas no significant difference in pri-
mordial, intermediate or secondary follicle counts was observed.
Within the oncological tissue experiment, the counts for primordial
follicles were estimated to be significantly lower from culture Day 2
onwards (78%, 95% CI 94% to 21%; P¼ 0.021 on Day 2) when
compared to Day 0 (Fig. 3). Intermediate follicle counts did not change
during culture (Fig. 3). Primary follicle counts were estimated to in-
crease significantly on Day 6 (compared to Day 0) with 170% higher
counts (95% CI þ14% to þ589%; P¼ 0.025) (Fig. 3).
The Hippo pathway. Based on the assumption that tissue fragmentation
promotes follicle activation and development through the Hippo path-
way, different Hippo pathway proteins were studied. RNA and protein
expression is discussed in oocyte, granulosa cells and stromal cells
with emphasis on the expression dynamics during culture and follicle
development, including attention for expression differences between
cortex of transgender and oncological patients (Fig. 2). Analysis of the
pathway in secondary follicles was limited due to the low number of
secondary follicles. Results are reported per target under analysis and
not by experiment.
Mammalian sterile 20-like protein kinase 1 and 2 (Mst1 and Mst2)
form a complex with Salvador1 to phosphorylate (and thus activate)
LATS1/2 (Badouel and McNeill, 2011). RT-qPCR analysis of follicles
derived from transgender ovarian cortex revealed a significantly down-
regulated expression when comparing Mst1 expression over different
culture days (P¼ 0.009; r2 ¼ 0.977) with significant subgroup ratios
between culture Day 0 and Day 6 (ratio Day 0/6¼ 30.797; 95% CI
11.649– 81.242; P< 0.05) and between culture Day 2 and Day 6 (ra-
tio Day 2/6¼ 11.738; 95% CI 2.623–52.538; P< 0.05). Mst2
appeared to be significantly down-regulated when comparing culture
Day 0 and Day 6 (ratio Day 0/6¼ 12.019; 95% CI 1.167–123.798,
P< 0.05) (Fig. 4). Sub-analysis of the oncological data did not reveal
any differences (data not shown).
Immunohistochemical study of Mst1 showed no difference in local-
isation when comparing tissue derived from transgender and oncologi-
cal patients. Regardless of the follicle stage or culture day, Mst1 was
always observed in the oocyte. The localisation within the oocyte was,
however, dynamic during follicle development. Mst1 was present in
the entire oocyte cytoplasm of the primordial, intermediate and pri-
mary follicle, followed by clustering around the nucleus in the second-
ary follicle and resulting in a nuclear localisation in the antral oocytes
(Fig. 4). Mst1 could also be stained in granulosa cells in follicles of the
Primordial follicle activation in ovarian tissue culture 7
Figure 3. Follicle distribution per culture day. Follicle distribution as a percentage of the total amount of follicles per culture day in transgen-
der men and oncological patients. Estimated follicle counts in primordial, intermediate, primary and secondary follicles in transgender men (red) and
oncological patients (green). Significant lower estimated primordial follicle counts were found on Days 2, 4 and 6 in the oncological group (78%;
95% CI 94% to 21%; P¼ 0.02 on Day 2) and on Day 4 and 6 in the transgender cohort (64%; 95% CI 83% to 23%; P¼ 0.008 on Day 4).
Primary follicle counts were estimated to increase significantly in oncological patients on Day 6 (estimated increase of 170%; 5% CI þ14% to þ589%;
P¼ 0.025). Significant higher estimated counts of secondary follicles were observed in transgender men on Day 4 (þ367%; 95% CI þ26% to
þ1630%; P¼ 0.021). All follicle counts are compared to the counts on Day 0. *Statistically significant in comparison to Day 0 (P< 0.05).





























.later stages independent of the culture days. Mst1 was also present in
the stromal cells, where no specific clustering around the follicle was
seen, nor was there a change in expression of MST1/2 or a change in
localisation of the MST1 staining pattern during culture or in different
stages of follicle development.
Salvador 1 (Sav1), the regulatory protein of Mst1/2, showed a sta-
ble expression in follicles and stromal cells over different follicle types
and different culture days in tissue derived from both transgender and
oncological patients (data not shown).
Large tumour suppressor homologues 1 and 2 (LATS1 and LATS2),
phosphorylated and activated by Mst1/2, in turn phosphorylates and
inhibits co-activators YAP and TAZ (Badouel and McNeill, 2011). As
for Sav1, RT-qPCR analysis did not reveal altered gene expression of
LATS1 and LATS2 during culture nor in the different follicle classes.
Also in stromal cells, no difference in gene expression could be
detected (data not shown).
The core of the Hippo pathway is the phosphorylation and
subsequent localisation of YAP. YAP accumulates in the nucleus
and activates the transcription of several growth-promoting genes
(Fan et al., 2013). pYAP by Lats1/2 results in cytoplasmic translocation
and, therefore, inactivation of YAP (Zhao et al., 2008). The localisation
and phosphorylation of YAP are often taken as a measure of the activ-
ity of the Hippo pathway; therefore, YAP and pYAP were studied us-
ing IHC (Gumbiner and Kim, 2014).
Overall, phosphorylated YAP (pYAP), the inactive form of YAP,
was predominantly expressed in the granulosa cells of the follicles
whereas YAP was predominantly, but not exclusively, located in the
oocyte. On Day 0, follicles of all maturation stages were dominated by
a pYAP expression and the presence of YAP in the oocyte gradually
diminished in the more mature follicles compared to primordial fol-
licles. Induced by ovarian tissue fragmentation, the presence of pYAP
diminished while YAP expression was induced in the oocyte and gran-
ulosa cells of maturing follicle stages and in later culture days (Fig. 5).
Intriguingly, comparing transgender and oncological patient popula-
tions, YAP expression was slightly different. On Day 0, YAP was
not expressed in granulosa cells derived from oncological patients, in
contrast to the transgender men cohort where YAP could be found in
the granulosa cells of primary and secondary follicles on Day 0. During
Figure 4. Mst analysis. Upper panels: Mst1 expression over different culture days with significant downregulated subgroup ratios between culture
Day 0 and Day 6 and between culture Day 2 and Day 6 in transgender follicles (left panel). Mst2 expression over different culture in transgender follicles
with significant down-regulated subgroup ratios between culture Day 0 and day (right panel). *Statistically significant. Lower panels: Representative images
of Mst1 expression (red dye) in primordial, intermediate, primary, secondary and antral follicle; underneath the same follicles stained with DAPI as a ref-
erence (in this example pictures: all transgender follicles on culture Day 6). Mst1 is present in the entire oocyte cytoplasm of the primordial and interme-
diate follicle, followed by clustering around the nucleus in the secondary follicle and resulting in a nuclear localisation in the antral oocytes. Scale bar ¼
50mm.
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Figure 5. YAP/pYAP presence in follicles: Representative images of YAP and pYAP expression in primordial, intermediate, pri-
mary, secondary and antral follicles. From left to right, increasing follicle stages and from top to bottom increasing culture days.
The left four columns illustrate the stainings of interest (green dye ¼ YAP and red dye ¼ pYAP). The right four columns are the same follicles stained
with DAPI as a reference. The top four rows (a) are follicles derived from transgender ovaries, the bottom four rows from oncological patients (b).
Grey squares ¼ follicles missing for analysis. Scale bar ¼ 25 mm. Induced by ovarian tissue fragmentation, the gradual disappearance of YAP in the oo-
cyte as on Day 0 could not be observed in the maturing follicle stages on culture Days 2, 4 and 6. In granulosa cells, YAP appears in increasing follicle
stages and in increasing culture days. During culture, YAP appeared earlier in transgender granulosa cells in all follicle development stages compared
to oncological granulosa cells. Phosphorylated YAP (pYAP) was observed in granulosa cells of follicles of every stage, independent of the culture days,
except for the disappearance of pYAP in primordial granulosa cells on Day 2 in both patient groups and the absence on culture Day 6 in almost all
granulosa cells of oncological patients, independent of the maturation stage.
























































































culture, YAP appeared in transgender granulosa cells in all follicle de-
velopment stages while YAP was absent in oncological granulosa cells
(Fig. 5).
In the surrounding stromal cells, YAP expression appeared discretely
on Day 4, in contrast to the YAP absence on the other culture days.
In the stromal cells of both oncological and transgender samples,
pYAP was diffusely expressed on Day 0 and disappeared gradually un-
til absence on Day 6.
CCN growth factors such as connective tissue growing factor
(CTGF) are up-regulated as increased nuclear YAP interacts with
TEAD (transcription factors containing the TEA/ATTS DNA-binding
domain) (Hsueh et al., 2015). This increased expression ultimately
results in cell growth and proliferation. CTGF mRNA in primordial fol-
licles appeared to be significantly up-regulated when comparing Day 2
to Day 4 (ratio Day 4/2¼ 0.082; 95% CI 0.007– 0.921; P< 0.05), but
not in other day to day comparisons (Fig. 6).
The PI3K/Akt pathway. Phosphatidylinositol-3-kinase (PI3K) is stimulated
by activated receptor tyrosine kinases (RTK), following the interaction
of diverse extracellular factors with their respective RTK (Hsueh et al.,
2015). From culture Day 0 until Day 4, PI3K was seen in the cyto-
plasm of primordial, intermediate and primary oocytes and in all granu-
losa cells, without change over the culture days. On Day 6, PI3K
expression disappeared. PI3K was present in the stromal cells, where
no clustering around the follicle could be observed. As in the granulosa
cells, PI3K expression disappeared in stromal cells on culture Day 6
(Fig. 7, upper panel).
Akt phosphorylation and thus activation occurs after PI3K induced
conversion of phosphatidylinositol-(4,5)-bisposphate (PIP2) into phos-
phatidylinositol-(3,4,5)-trisposphate (PIP3) and recruitment and activa-
tion of phosphatidylinositol-dependent kinases (Hsueh et al., 2015).
Akt was localised as a spot in the oocytes cytoplasm of primordial, in-
termediate and primary follicles from Day 0 until Day 6. Secondary fol-
licles were too limited in number to evaluate the presence of Akt. Akt
could not be observed in the granulosa cells in any of the follicle
stages, nor in the stromal cells. There was no difference in the findings
between oncological and transgender patients (Fig. 7, middle panel).
The active counterpart, pAkt, was diffusely located in the entire oo-
cyte cytoplasm on Day 0 in primordial, intermediate and primary fol-
licles. This diffuse localisation reorganised into a cytoplasmic spot on
later culture days, independent of the follicle stage. Again, secondary
follicles could not be evaluated due to the limited numbers. In granu-
losa and stromal cells, pAkt expression was limited in oncological ovar-
ian tissue on Day 0 and completely absent in all other conditions
(Fig. 7, middle panel).
Forkhead box protein O1 (FOXO1) is suppressed by nuclear trans-
location of Akt and subsequent phosphorylation of transcription factor
FOXO1 resulting in nuclear extrusion (Hsueh et al., 2015). In the acti-
vated form FOXO1 interacts with dormancy factors, inhibiting follicles
from activation and growth.
FOXO1 was predominantly expressed in the oocyte compared to
the granulosa cells and could not be observed in the stromal cells.
FOXO1 was seen as a hotspot in the oocyte in primordial, intermedi-
ate and primary follicles, from Day 0 until Day 4 (Fig. 7, lower panel).
On Day 6, FOXO1 could not be detected by IHC in the primordial
oocyte. In the intermediate and primary oocytes, FOXO1 could still
be seen after 6 days of tissue culture. Again, secondary follicles could
not be evaluated because of their low number.
The inactive phosphorylated 1 (pFOXO1) was observed in both
oocyte and granulosa cells. In the oocyte, pFOXO1 was observed in
all oocytes on every culture day, except in primordial follicles on Day
6. In granulosa cells, pFOXO1 could not be identified by IHC in pri-
mordial granulosa cells on culture Day 6 and in derived primordial
granulosa cells from oncological patients on every culture day and in
intermediate granulosa cells on Day 0 and 2, in contrast to the pres-
ence of pFOXO in all other conditions (Fig. 7, lower panel).
Phosphorylated FOXO1 was not expressed or very limited in stromal
cells (data not shown).
Figure 6. CTGF expression in primordial follicles: RT-
qPCR results: CTGF mRNA in primordial follicles
appeared to be significantly up-regulated when comparing
Day 2 to Day 4 (ratio Day 4/2 5 0.082; 95% CI 0.007– 0.921;
P < 0.05), but not in other day-to-day comparisons.
*Statistically significant. P< 0.05 was considered to be statistically
significant.










This work maps a detailed progression in follicle development and the
changes in the Hippo and PI3K/Akt pathway during a 6 days in-vitro
ovarian tissue culture in order to optimise the use of primordial
follicles in-vitro. For this purpose, ovarian tissue from transgender and
oncological patient populations was used. Previous work in in-vitro tis-
sue culture optimisation was performed using tissue was obtained dur-
ing caesarean section (Telfer et al., 2008) or from patients diagnosed
with premature ovarian insufficiency (POI) (Kawamura et al., 2016).
Figure 7. IHC PI3K Akt pathway. Upper panel: PI3K was seen in the cytoplasm of primordial, intermediate and primary oocytes and in all gran-
ulosa cells (red dye, oncological primary follicle culture Day 4). Middle panel: Akt (green dye) and pAkt (red dye) (oncological intermediate follicles
on culture Day 0 and 2). Akt was localised as a hotspot in the oocytes cytoplasm of primordial, intermediate and primary follicles from Day 0 until
Day 6. The active counterpart, phosphorylated Akt (pAkt), was diffusely located in the entire oocyte cytoplasm on Day 0 in primordial, intermediate
and primary follicles. This diffuse localisation reorganised into a cytoplasmic hotspot on later culture days, independent of the follicle stage. Lower
panel: FOXO1 (green dye) and pFOXO1 (red dye) (intermediate follicles culture Day 2 from oncological patients and transgender men). FOXO1
was seen as a hotspot in the oocyte in primordial, intermediate and primary follicles, from Day 0 until Day 4. The inactive phosphorylated 1
(pFOXO1) was observed in both oocyte and granulosa cells. In granulosa cells, pFOXO1 could not be found in from oncological patients derived pri-
mordial granulosa cells on every culture day and in intermediate granulosa cells on Day 0 and 2 compared to pFOXO presence in all other conditions.
The right panel of the picture pairs represents the same follicles stained with DAPI as a reference. Scale bar ¼ 25 mM.
























































































Perturbation of the growing follicle pool might be expected due to
high levels of hCG and oestradiol at the time of caesarean section,
however, effects on the dormant follicle pool during pregnancy re-
main undescribed so far. Harvesting ovarian tissue after a prolonged
exposure to FSH and LH in POI patients might affect the residing
follicle pool as pre-antral follicles growth are proven to be FSH re-
sponsive (Hsueh et al., 2015). In our current setting, one may ques-
tion the effect of testosterone on folliculogenesis and on the studied
pathways, as ovarian tissue was obtained from transgender persons
after a period of exogenous testosterone exposure. On the other
side, oncological disease might influence follicle growth and develop-
ment as well. Hence, a strength of this work is the use of ovarian
tissue of the target population groups. An optimised ovarian tissue
culture model for both target populations, including an individualised
approach in both groups depending on the defined needs, is there-
fore clinically relevant.
First, follicle classification and progression was studied by HE-based
follicle counting and grading. Sections on Day 0 enabled us to assess
the follicular cohort at baseline level (before tissue preparation and in-
vitro culture effects) and were concordant with previous reports
(Schmidt et al., 2003; Telfer and Zelinski, 2013; De Roo et al., 2017).
The disparity between follicle numbers can be explained by the innate
heterogeneity of follicle distribution in the ovary. The cortical follicle
count was then used in analysing the shift in follicles during in-vitro
culture. A significant drop in primordial follicles was seen in the onco-
logical cohort on Day 2 and in transgender cohort on Day 4.
Intermediate follicle counts showed a non-significant trend to increase
during culture and this follicle recruitment and growth resulted in a sig-
nificant rise in primary follicles on Day 6 in oncological patients and al-
though limited in absolute numbers, a significant increase in secondary
follicles on Day 4 in the transgender cohort. These results confirm pri-
mordial follicle activation by mechanical manipulation of the cortical
strips (Telfer et al., 2008; Telfer and Zelinski, 2013). Subsequent antral
follicle development could not be observed in the current in-vitro cul-
ture setup.
Subsequently, the effect of ovarian tissue fragmentation and culture
on the Hippo and PI3K/Akt pathway was investigated, confirming the
primordial follicle activation. Ovarian tissue preparation and culture in-
duced the inhibitory pYAP to disappear in granulosa cells of primordial
follicles on Day 2. The stimulatory YAP on the contrary appeared in
primordial granulosa cells over increasing culture days. Looking at the
YAP target CTGF, a significantly up-regulated CTGF was noted in pri-
mordial follicles when comparing Day 2 and Day 4, clearly showing an
effect on the Hippo pathway in primordial follicles during tissue cul-
ture. During culture, YAP expression in the oocyte did not decrease
over increasing follicle stages as on Day 0, illustrating that Hippo path-
way disruption also influences later follicle stages. This is in line with
previous work by Kawamura et al. (2013, 2016), where cortex frag-
mentation was applied for as a technique for in-vitro activation of ovar-
ian follicle growth.
A remarkable difference is the limited YAP expression in oncological
granulosa cells over all culture days and follicle types, when compared
to transgender samples. This might indicate a possible effect of either
the oncological disease or an influence of testosterone priming prior
to surgery. In a previously published study (De Roo et al., 2017), we
could not reveal a quantitative difference in follicle counts and distribu-
tions, however, testosterone might influence the surrounding matrix as
well. Androgen receptor expression is described in stromal cells
(Horie et al., 1992; Chadha et al., 1994; Gervásio et al., 2014) and tes-
tosterone administration is known to cause a thicker ovarian cortex
with ovarian stromal hyperplasia (Ikeda et al., 2013). Matrix stiffening is
furthermore known to enhance YAP activation in cancer-associated
fibroblasts (Calvo et al., 2013). Hence, these testosterone-induced
changes could result in a stiffer cortical ‘niche’, favouring Hippo path-
way signalling where disruption might cause a more pronounced effect
(Halder et al., 2012; Hsueh et al., 2015).
Following the direct effects on YAP localisation and subsequent up-
regulation of CTGF, a down-regulated expression of Mst1 and Mst2
was observed. These findings are in line with previous work of Xiang
et al. where a decreased expression of negative regulators of the
Hippo pathway had similarly been observed in an 8-day mouse ovary
culture. This can be part of the feedback suppression allowing it to be
expressed (Xiang et al., 2015).
In this setting, Mst1 has a striking spatiotemporal evolution in the
maturing oocyte, reflected by a cytoplasmic localisation in the primor-
dial, intermediate and primary follicle, gradually reorganising through
clustering around the secondary oocyte nucleus (regardless of the cul-
ture duration) towards a nuclear localisation in the antral follicle.
Mst1/2 proteins are involved in stress-induced apoptosis, and if acti-
vated in the apoptosis pathway, Mst1/2 translocates to the nucleus
(Pan, 2010). This most probably indicates inadequate support of the
more mature follicle stages. Because of the scarcity of this valuable ma-
terial at the different time points, apoptosis was not further
investigated.
In addition to the Hippo pathway, the involvement of the PI3K-
Akt pathway in primordial follicle activation was studied. Staining
on pathway targets showed a stable expression pattern of PI3K,
Akt and FOXO1/pFOXO1 from culture Day 0 to Day 4 in pri-
mordial, intermediate and primary follicles. This could indicate a
rather limited role for the PI3K-Akt pathway in follicle develop-
ment during tissue culture. Another hypothesis is the possible later
involvement of the PI3K-Akt pathway in follicle development dur-
ing tissue culture (Masciangelo et al., 2020). This descriptive analy-
sis is a valuable start for research. However, interfering with this
signalling pathway using pathway stimulators and/or inhibitors,
with bpv (hopic) as a PTEN inhibitor and 740YP as an PI3K stimu-
lator, would enrich our knowledge on the specific role of the
PI3K-Akt pathway in primordial follicle activation in tissue culture
(Kawamura et al., 2013).
The most important changes in primordial follicle activation and
Hippo signalling appeared to happen from Day 0 to Day 4 in vitro.
These findings lead to recommending a shorter first phase of tissue
culture, preferably tissue source specific, being 2 days for oncological
and 4 days for transgender cortex. An earlier change to pre-antral folli-
cle medium conditions can be of interest to increase tissue culture effi-
cacy. Further research is needed to evaluate if follicles at this point are
competent to be removed from the tissue and to continue growth
and maturation after isolation.
In the stromal cells, Hippo pathway targets were either absent
(Mst) or diffusely present (YAP-pYAP). Apart from a diminished YAP-
pYAP expression on culture Day 6, other changes in expression (IHC)
or differential expression (RT-qPCR) over the different culture days
could not be described. We can hypothesise that, although there are
clearly changed by stretching and cutting the ovarian cortex, these
























































































changes probably do not affect the studied pathways in the stromal
cells. Changes in the extracellular matrix and cell adhesion seem to be
detected by the follicular unit itself.
The massive activation of primordial follicles based on Hippo in-
terruption may also have implications for tissue cryopreservation
for transplantation. If transplantation is the intended technique
upon thawing, the primordial follicle pool might benefit from larger
strips (and thus less Hippo pathway disruption) where less recruit-
ment (and thus burnout) could be a huge benefit. Hippo pathway
disruption does not selectively recruit primordial follicles, but
might also regulate growth in more advanced follicle stages
(Kawamura et al., 2013; Hsueh et al., 2015). Tissue preparation
for cryopreservation includes the removal of the medulla by scrap-
ing with a scalpel to prepare the cortical tissue to the required
thickness of 1 mm. This most probably results physical removal of
secondary and early pre-antral follicles, mostly situated on the dis-
section plane as previously demonstrated (De Roo et al., 2017;
Herraiz et al., 2020; Lunding et al., 2020), but also in an unin-
tended activation and burnout of residing follicles of all maturation
stages in the cortex fragments. If so, ovarian tissue preparation for
cryopreservation might benefit by keeping the medulla (partially)
intact. However, cryopreserving larger cortical strips with or with-
out medulla is challenged by an adequate and equal diffusion of
cryoprotectants through the tissue without harming the tissue by
prolonged exposure to the cryoprotectant (Martinez-Madrid et al.,
2004). Another option would be pre-treatment of smaller cortex
to limit Hippo pathway disruption effects, for example using
Diaphanous (DIAPH) formins that suppress actin depolymerisation
(Hsueh et al., 2015).
A limitation of this work is the small sample size, which is inherent
to this type of study subject. Cryopreserved tissue for fertility preser-
vation has only limited availability for research, and large amounts of
tissue are needed to reduce inter-patient variation in different down-
stream analysis techniques. A particular and specific weakness of this
study is the inability to include an age-matched control group. In the
described age group, oophorectomy and cryopreservation of ovarian
tissue in healthy fertile women rarely occur, making a comparative tis-
sue culture and downstream pathway analysis not feasible. The findings
in this work remain however, valuable as previously suggested path-
ways are now extensively documented in the target groups of this tis-
sue culture technique.
In conclusion, this work describes the detailed evolution of follicle
development and a follicle-specific Hippo pathway involvement during
6 days of in-vitro tissue culture. The results highlight a Hippo pathway
driven primordial follicle activation in a culture system where the cul-
ture efficiency could be increased by an earlier change to optimal pre-
antral follicle conditions. Moreover, tissue preparation for culturing
might benefit from adaptations for different target patients, in this
study illustrated by a different follicle activation following Hippo path-
way disruption in the cortex derived from transgender men compared
with that from oncological patients.
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Supplementary data are available at Human Reproduction Open online.
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